Belladonna and Opium Suppositories CII
Generic Name and Formulations:
Belladonna extract (powdered), opium (powdered); 16.2mg/30mg, 16.2mg/60mg.
Indications for Belladonna and Opium Suppositories:
Moderate to severe pain associated with ureteral spasms.
1 supp rectally once or twice daily; max 4 doses/day.
Glaucoma. Severe hepatic or renal disease. Asthma. Narcotic idiosyncrasies. Respiratory depression. Convulsive disorders. Acute alcoholism. Delirium tremens. Premature labor.
Idiosyncrasies to atropine and related drugs. Cardiac disease. Incipient glaucoma. GI or GU obstruction. Increased intracranial pressure. Toxic psychosis. Myxedema. Drug abusers. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.
Antispasmodic + opioid.
CNS effects potentiated with alcohol, other CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics. Potentiated by anticholinergics.
Drowsiness, anticholinergic effects (eg, dry mouth, urinary retention, dizziness, blurred vision, constipation), photophobia, tachycardia, GI upset, pruritus, urticaria.
Formerly known under the brand name B&O Supprettes 15A, B&O Supprettes 16A.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Cycle Patterns Associated With Treatment Response in Bipolar Disorders
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder